Article Versions Notes

Takeda T, Yamada T, Kunimatsu Y, Tanimura K, Morimoto K, Shiotsu S, Chihara Y, Okada A, Horiuchi S, Hibino M, et al. Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study. Cancers. 2023; 15(5):1543. https://doi.org/10.3390/cancers15051543

Takeda, Takayuki, Tadaaki Yamada, Yusuke Kunimatsu, Keiko Tanimura, Kenji Morimoto, Shinsuke Shiotsu, Yusuke Chihara, Asuka Okada, Shigeto Horiuchi, Makoto Hibino, and et al. 2023. "Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study" Cancers 15, no. 5: 1543. https://doi.org/10.3390/cancers15051543

Takeda, T., Yamada, T., Kunimatsu, Y., Tanimura, K., Morimoto, K., Shiotsu, S., Chihara, Y., Okada, A., Horiuchi, S., Hibino, M., Uryu, K., Honda, R., Yamanaka, Y., Yoshioka, H., Kurata, T., & Takayama, K. (2023). Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study. Cancers, 15(5), 1543. https://doi.org/10.3390/cancers15051543